Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
about
In vitro inhibition of lipid accumulation induced by oleic acid and in vivo pharmacokinetics of chitosan microspheres (CTMS) and chitosan-capsaicin microspheres (CCMS)Treatment options for nonalcoholic steatohepatitis - a safety evaluation.Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice.In NAFLD, You Are What You Eat, Not Simply How Much You EatDietary Flaxseed Oil Prevents Western-Type Diet-Induced Nonalcoholic Fatty Liver Disease in Apolipoprotein-E Knockout Mice.Aberrant hepatic lipid storage and metabolism in canine portosystemic shunts.Non-alcoholic Fatty Liver Disease: A Clinical Update.The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials.Association between urine retinol-binding protein levels and nonalcoholic fatty liver disease: A cross-sectional study in Chinese population.Curcumin suppresses Notch‑1 signaling: Improvements in fatty liver and insulin resistance in rats.Acute loss of iron-sulfur clusters results in metabolic reprogramming and generation of lipid droplets in mammalian cells.Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis
P2860
Q33810854-C1955869-62EE-4A22-BBDE-6D83367392A6Q38713765-73153449-3C12-4F2D-B48F-E3CDBCEF306FQ40305562-FC1511FE-DC41-416C-9213-15EC50D2BC33Q41419929-3F4D5594-A06E-4897-8FFE-C7630F854340Q42346715-F4915FAF-38AA-4B41-A98F-490D20002315Q42730581-E8561D53-9A94-4FD0-965F-8336431A1295Q46029063-4C563071-5EB3-40EE-9C53-CB38F9749F18Q47100244-B484709C-0D69-4FC1-990C-77BAAEA1FA17Q47132791-22BC56DC-8F6E-4DB7-BE83-FC4AAA8A1EB9Q47342109-AB491B27-9588-41A6-B0A5-3CA1786A754AQ47426820-F248BEDE-6A2C-4A2B-B550-0CC42B115BF0Q55078174-6F7ED631-DA5B-4ADE-9085-FB5A0ED1E0A4Q57192818-1D914C0E-412E-4190-BA62-7F495D046F36
P2860
Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
@ast
Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
@en
type
label
Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
@ast
Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
@en
prefLabel
Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
@ast
Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
@en
P2093
P2860
P1476
Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
@en
P2093
Amanke Oranu
Rotonya M Carr
Vandana Khungar
P2860
P304
P356
10.1016/J.GTC.2016.07.003
P577
2016-10-13T00:00:00Z